A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization

NCT ID: NCT01601197

Last Updated: 2012-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-05-31

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Immunization injections are a significant source of pain for infants. Tactile stimulation (rubbing/applying pressure) may be an effective and feasible pain-relieving intervention - it is cost neutral, and has been shown to be effective in children and adults undergoing injections. The aim of this study is to determine the added benefit of tactile stimulation when added to other proven analgesic interventions during routine infant immunization injections.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Immunization injections are a significant source of pain for infants. At present, effective and feasible pain-relieving interventions include sugar water, fast injection without aspiration, and holding infants during the procedure. These methods, however, do not eliminate pain in all infants. Additional interventions are therefore needed.

Tactile stimulation (rubbing/applying pressure) has been shown to reduce injection pain in children and adults, and may be a suitable intervention for infant injections. It is cost neutral, requires no preparation, and is easily incorporated into practice.

The aim of this study is to determine the effectiveness of tactile stimulation when added to other proven analgesic interventions on reducing pain during infant immunization injections.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Infants Immunization Pain Management

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

immunization pain management infants tactile stimulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tactile stimulation

Ipsilateral limb will be rubbed immediately before, during and after immunization injection(s)

Group Type EXPERIMENTAL

Tactile stimulation

Intervention Type BEHAVIORAL

Immunizer will rub the ipsilateral limb before, during and after immunization injection(s)

No tactile stimulation

There will be no tactile stimulation of ipsilateral limb before, during and after immunization injection(s)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tactile stimulation

Immunizer will rub the ipsilateral limb before, during and after immunization injection(s)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* infants 1-12 months of age receiving routine immunization injections in an outpatient pediatric clinic in Toronto

Exclusion Criteria

* impaired neurological development
* history of seizure
* use of topical anesthetics
* use of sedatives or narcotics within 24 hours
* fever or illness that would prevent administration of vaccine
* prior participation in the trial
Minimum Eligible Age

1 Month

Maximum Eligible Age

12 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anna Taddio

Associate Professor, Leslie Dan Faculty of Pharmacy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anna Taddio, PhD

Role: PRINCIPAL_INVESTIGATOR

Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario M5S 3M2 Canada

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Tommy Ho Pediatric Clinic

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anna Taddio, PhD

Role: CONTACT

Phone: 416-978-8822

Email: [email protected]

Mary-Ellen Hogan, PharmD

Role: CONTACT

Phone: 416-978-1466

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anna Taddio, PhD

Role: primary

Mary-Ellen Hogan, PharmD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Taddio A, Ho T, Vyas C, Thivakaran S, Jamal A, Ilersich AF, Hogan ME, Shah V. A randomized controlled trial of clinician-led tactile stimulation to reduce pain during vaccination in infants. Clin Pediatr (Phila). 2014 Jun;53(7):639-44. doi: 10.1177/0009922814526976. Epub 2014 Mar 14.

Reference Type DERIVED
PMID: 24634424 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

27518

Identifier Type: -

Identifier Source: org_study_id